Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

Ribosome Profiling

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Revealing the genetic regulation of wood traits and secondary cell wall development in <i>Ginkgo biloba</i>: an integrated analysis from the perspectives of GWAS, TWAS, and WGCNA.

Horticulture research·2026

Same author

Distinct and shared synergistic effects of high-fat and high-iron diets on liver tumorigenesis and transcriptomic remodeling in mice.

bioRxiv : the preprint server for biology·2026

Same author

Role of Bevacizumab in Multiple Glioblastomas: A Retrospective Single-Center Analysis.

Neurosciences (Riyadh, Saudi Arabia)·2026

Same author

MRDviz: an integrated platform for interactive visualization and joint simulation of minimal residual disease trajectories and associated survival outcomes.

Bioinformatics advances·2026

Same author

Selective elimination of circulating effector CD8 T cells via LTβR blockade separates anti-CD137 efficacy from toxicity.

Science advances·2026

Same author

The ANXA2P1-hnRNP F-HK2/c-Myc Positive Feedback Loop Promotes Proliferation and Glycolytic Metabolism in Gastric Cancer.

International journal of biological sciences·2026

Same journal

Editorial: Technologies for RNA Detection.

Bio-protocol·2026

Same journal

One-Step Affinity Purification of MarathonRT Reverse Transcriptase for RNA Sequencing Applications.

Bio-protocol·2026

Same journal

Enhanced RNA-Seq Expression Profiling and Functional Enrichment in Non-model Organisms Using Custom Annotations.

Bio-protocol·2026

Same journal

Using Combined Fluorescent In Situ Hybridization With Immunohistochemistry to Co-localize mRNA in Diverse Neuronal Cell Types.

Bio-protocol·2026

Same journal

Stepwise Protocol for Alternative Splicing Analysis in Single-Cell SMART-Seq2 RNA-Seq Data.

Bio-protocol·2026

Same journal

Enriching Bacteria-Specific RNA From Host Samples Before NGS With Transcript-Capture.

Bio-protocol·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 1, 2025

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

Approaching RNA-seq for Cell Line Identification.

Tabrez A Mohammad¹, Yidong Chen^1,2

¹Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, Texas, USA.

|November 9, 2020

Summary

This summary is machine-generated.

A new method, CeL-ID, authenticates cancer cell lines using RNA-seq genomic variants. This cost-effective approach addresses contamination and misidentification, crucial for reliable cancer research and drug development.

Keywords:

CeL-ID Cell integrity Cell line authentication Cell line identification Contamination detection RNA-seq variant profiles SNP

More Related Videos

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Published on: May 16, 2020

Single-cell RNA-Seq of Defined Subsets of Retinal Ganglion Cells

Single-cell RNA-Seq of Defined Subsets of Retinal Ganglion Cells

Published on: May 22, 2017

Related Experiment Videos

Last Updated: Dec 1, 2025

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

RNA Next-Generation Sequencing and a Bioinformatics Pipeline to Identify Expressed LINE-1s at the Locus-Specific Level

Published on: May 19, 2019

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Published on: May 16, 2020

Single-cell RNA-Seq of Defined Subsets of Retinal Ganglion Cells

Single-cell RNA-Seq of Defined Subsets of Retinal Ganglion Cells

Published on: May 22, 2017

Area of Science:

Biomedical Research
Genomics
Cancer Biology

Background:

Cancer cell lines are vital for research but face contamination and misidentification issues.
Current cell line authentication methods are often inaccessible, slow, and expensive.
There is a critical need for a cost-effective and accessible cell line authentication solution.

Purpose of the Study:

To develop and validate CeL-ID, a novel, cost-effective method for cancer cell line authentication.
To leverage genomic variants from RNA-seq data for accurate cell line identification.
To provide a reliable tool for ensuring the integrity of cancer cell line models.

Main Methods:

Developed CeL-ID, utilizing genomic variants from RNA-seq data.
Trained and tested CeL-ID on over 900 public RNA-seq datasets from the Cancer Cell Line Encyclopedia (CCLE).
Generated cell line-specific variant profiles and compared them using allele frequencies and coverage depth.

Main Results:

CeL-ID effectively distinguishes between different cancer cell lines based on variant profiles.
Identical, synonymous, and derivative cell lines showed high variant identity and correlated allelic fractions.
The method can also estimate cross-contamination using a linear mixture model.

Conclusions:

CeL-ID offers a robust and cost-effective solution for cancer cell line authentication.
This method enhances the reliability of cancer research by ensuring cell line integrity.
CeL-ID addresses a significant challenge in biomedical research, improving data accuracy and reproducibility.